Financial News
Repare Therapeutics Inc (NQ: RPTX )
3.160
+0.150
(+4.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
All News about Repare Therapeutics Inc
![](https://mms.businesswire.com/media/20240806289967/en/2207286/22/RT-001-Repare-Therapeutics-Logo.jpg)
![](https://mms.businesswire.com/media/20240626903583/en/2169869/22/RT-001-Repare-Therapeutics-Logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Recap: Repare Therapeutics Q4 Earnings
February 28, 2024
Via Benzinga
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2024/05/08/xrdDAFq8R-nQ7g2-j6031844861216095376-t23.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/08/xrdDAFih-sWqhI2-j46865321670-t23051015.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240430915822/en/2109521/22/debiopharm_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://cdn.benzinga.com/files/images/story/2024/04/15/bz-pharma-briefs.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240321731194/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20240315655552/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Repare Therapeutics to Participate in Two Upcoming Investor Conferences
February 29, 2024
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240216706377/en/774509/22/new_KM_logo.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/Roche_0.png?width=1200&height=800&fit=crop)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Repare Therapeutics to Regain Global Rights to Camonsertib
February 12, 2024
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.